New phase 3 data show meaningful improvement in antibody-negative myasthenia gravis, for which treatment options are limited ...
CINCINNATI, June 19-- University of Cincinnati's Academic Health Center issued the following news release: Myasthenia gravis is a chronic autoimmune neuromuscular disease whose name, translated from ...
New York, March 10, 2025 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association (MDA) welcomes the U.S. Food and Drug Administration (FDA) approval of the expanded indication of Alexion/AstraZeneca’s ...
Myasthenia gravis is a life-long (chronic) autoimmune condition, which means that the body’s immune system attacks its own healthy cells. Most people with generalized myasthenia gravis (gMG) have ...
Takenobu Y, Kikuchi T, Ishikawa D, et al. Rozanolixizumab as rescue therapy in triple seronegative refractory generalized ...
The myasthenia gravis treatment landscape is expanding with new therapies and mechanisms, enhancing management options. Treatment decisions are complex due to patient heterogeneity and idiosyncratic ...
Please provide your email address to receive an email when new articles are posted on . Nipocalimab led to significant improvements in disease-specific metrics from baseline among patients with ...
For several decades, thymectomy has been an option for the treatment of myasthenia gravis, a rare, long-term, autoimmune neuromuscular disease. This randomized clinical trial, carried out in 67 ...
Myasthenia gravis, or MG, is "a chronic autoimmune neuromuscular disorder that causes muscle weakness and fatigue," says Hesterlee. It occurs "when a person’s immune system is essentially attacking ...
One man shares how his life and work were upended before finally getting answers. Learn about new treatments are helping patients regain control and improve quality of life. Myasthenia gravis is ...
Myasthenia gravis is a lifelong (chronic) autoimmune condition, which means that the body’s immune system attacks its own healthy cells. Most people with generalized myasthenia gravis (gMG) have ...